ADVERTISEMENT
-
Publications
-
Meetings
-
Education
-
About
-
Resources
Advertisement
ADVERTISEMENT
BioStem Technologies announces the initiation of the BR-AC-DFU-101 clinical trial to evaluate BR-AC (AmnioWrap 2) vs SoC for non-healing DFUs. The study will be conducted at 10 sites across the US with an expected completion date of the end of 2025.
Advertisement
Advertisement
Advertisement